再生元制药公司与赛诺菲宣布,双方已就现有许可及合作协议达成第六次修订。该消息来自一份提交至美国证券交易委员会的文件。
再生元制药公司与赛诺菲宣布,双方已就现有许可及合作协议达成第六次修订。该消息来自一份提交至美国证券交易委员会的文件。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.